Form D · Pharmaceuticals
JN Medical Corp
Omaha, NE · CIK 0001601279
Offering snapshot reported Apr 25, 2014 · SEC filing
- Reported sold
- $501K Offering amount: $501K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Nov 21, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2014 | Initial | $500,832 | No comparison | 1 | SEC filing |
| Apr 25, 2014 | Initial | $2,012,000 | No comparison | 1 | SEC filing |
| Apr 22, 2014 | Initial | $9,900,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-216258
Source: Form D, filed Apr 25, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Purnachandra R Aramalla | Director |
| Jeeri V Lakshmi | Director |
| Jeeri R. Reddy | Director, Executive, Promoter |
| H. Rajender Reddy | Director |
| Prasadrao Yarlagadda | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2720 North 84 Th St.
Omaha, NE, 68134
Omaha, NE, 68134